Cervicovaginal metabolome is predictive of endometrial cancer and tumor characteristics and leveraged for risk stratification

被引：0
|
作者：
Chase, Dana [1 ]
Shukla, Soham [2 ]
Moore, Julia [2 ]
Boyle, Tirza [2 ]
Lim, Jonathan [2 ]
Perhanidis, Jessica [3 ]
Hurteau, Jean [3 ]
Schilderd, Jeanne [4 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] GSK, Upper Providence, PA USA
[3] GSK, Waltham, MA USA
[4] GSK, Philadelphia, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2300
引用
收藏
页码：S398 / S399
页数：2
相关论文
共 50 条
  • [21] ENDOMETRIAL CANCER IMMUNOHISTOCHEMICAL RISK STRATIFICATION IN A LARGE UTERINE-CONFINED CANCER SERIES
    Perrone, E.
    De Felice, F.
    Capasso, I.
    Arciuolo, D.
    Distefano, E.
    Lorusso, D.
    Zannoni, G. F.
    Scambia, G.
    Fanfani, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A74 - A75
  • [22] Endometrial cancer risk and survival by tumor MMR status
    Nagle, Christina M.
    O'Mara, Tracy A.
    Tan, Yen
    Buchanan, Daniel D.
    Obermair, Andreas
    Blomfield, Penny
    Quinn, Michael A.
    Webb, Penelope M.
    Spurdle, Amanda B.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (03)
  • [23] Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling
    Eiji Hishinuma
    Muneaki Shimada
    Naomi Matsukawa
    Yoshiko Shima
    Bin Li
    Ikuko N. Motoike
    Yusuke Shibuya
    Tatsuya Hagihara
    Shogo Shigeta
    Hideki Tokunaga
    Daisuke Saigusa
    Kengo Kinoshita
    Seizo Koshiba
    Nobuo Yaegashi
    Cancer & Metabolism, 11
  • [24] Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling
    Hishinuma, Eiji
    Shimada, Muneaki
    Matsukawa, Naomi
    Shima, Yoshiko
    Li, Bin
    Motoike, Ikuko N.
    Shibuya, Yusuke
    Hagihara, Tatsuya
    Shigeta, Shogo
    Tokunaga, Hideki
    Saigusa, Daisuke
    Kinoshita, Kengo
    Koshiba, Seizo
    Yaegashi, Nobuo
    CANCER & METABOLISM, 2023, 11 (01)
  • [25] The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer
    Nakamura, Keiichiro
    Hongo, Atsushi
    Kodama, Junichi
    Hiramatsu, Yuji
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 82 - 87
  • [26] Pathological characteristics and risk stratification in patients with stage I endometrial cancer: utility of apparent diffusion coefficient histogram analysis
    An, Taein
    Kim, Chan Kyo
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1126):
  • [27] Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations
    Dai, Donghai
    Thiel, Kristina W.
    Salinas, Erin A.
    Goodheart, Michael J.
    Leslie, Kimberly K.
    Bosquet, Jesus Gonzalez
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 150 - 157
  • [28] MRI-based Radiomics Models for Pretreatment Risk Stratification of Endometrial Cancer
    Kido, Aki
    Nishio, Mizuho
    RADIOLOGY, 2022, 305 (02) : 387 - 389
  • [29] Stratification of risk groups according to survival after recurrence in endometrial cancer patients
    Shim, Seung-Hyuk
    Kim, Dae-Yeon
    Kim, Hyun Jung
    Lee, Shin-Wha
    Park, Jeong-Yeol
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    MEDICINE, 2017, 96 (21)
  • [30] External validation study of endometrial cancer preoperative risk stratification model (ENDORISK)
    Vinklerova, Petra
    Ovesna, Petra
    Hausnerova, Jitka
    Pijnenborg, Johanna M. A.
    Lucas, Peter J. F.
    Reijnen, Casper
    Vrede, Stephanie
    Weinberger, Vit
    FRONTIERS IN ONCOLOGY, 2022, 12
12345